LFWD

Lifeward Ltd.

Insider Trades

NameValueActionPriceCurrent Price
Lynch JeannineVP Of Market Access & Strategy
$1.0k1.6k shares
SellSep 2, 2025
$0.64
--
Jasinski Lawrence JDirector, Officer: Chief Executive Officer
$2.4k1.9k shares
SellMay 21, 2025
$1.26
--
Lind Global Fund II LP10 Percent Owner
$370k190.7k shares
SellJan 7, 2025
$1.94
--
Lind Global Fund II LP10 Percent Owner
$1.9k700 shares
SellJan 7, 2025
$2.69
--
Lind Global Fund II LP10 Percent Owner
$1.0M298.4k shares
SellJan 6, 2025
$3.46
--
Lind Global Fund II LP10 Percent Owner
$251k83.3k shares
SellJan 6, 2025
$3.01
--

News

globenewswire.comLifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platformglobenewswire.comMay 19seekingalpha.comLifeward Ltd. (LFWD) Q1 2026 Earnings Call Transcriptseekingalpha.comMay 15zacks.comLifeward (LFWD) Reports Q1 Loss, Lags Revenue Estimateszacks.comMay 15globenewswire.comLifeward Reports First Quarter 2026 Financial Resultsglobenewswire.comMay 15globenewswire.comLifeward to Report First Quarter 2026 Financial Results on May 15, 2026globenewswire.comMay 11